Company
United StatesPublic company, OTC: SYBXSYNLOGIC (OTC: SYBX), Cambridge, MA – FDA Inspections
Inspection records and compliance data for SYNLOGIC in Cambridge, Massachusetts. 1 FDA inspection on record, last inspected January 23, 2019. Publicly traded as OTC: SYBX.
Company Profile
This profile covers SYNLOGIC based in Cambridge, Massachusetts, United States.
FDA Inspection History
- FDA inspections
- 1
- OAI
- 0
- VAI
- 0
- NAI
- 1
- Form 483s
- 0
- Warning letters
- 0
Inspected January 23, 2019.
FDA inspections (1)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| January 23, 2019 | NAI | Biologics · Bioresearch Monitoring | 1079177 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Charlton Memorial Southcoast Hospitals Group Campus
Baystate Franklin Medical Center, BB
Raymond T. Chung, M.D.
Southcoast Hospitals Group, Inc. / St. Luke's Hospital Blood Bank
Brigham and Women's Hospital Blood Donor / Transfusion Service
MGH Bone Bank
Zepto Metrix Corporation
Southcoast Health Tobey Hospital
Medtronic
Mount Auburn Hospital Blood Bank
Company Information
Name
SYNLOGIC
Stock ticker
SYBX
Exchange
OTC
Price as of
November 6, 2026
FEI Number
3014249614
Address
301 Binney St Rm 402, Cambridge, Massachusetts 02142, United States
Country
United States
ID: 327a97fb-4c5e-47fb-88d6-59dc337b89ac